![]() |
|
![]() |
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsored by: |
Laval University |
Information provided by: | Laval University |
ClinicalTrials.gov Identifier: | NCT00686491 |
Eleven National Sports Teams are located in the Quebec Metropolitan Area. In these groups, many athletes are aiming for Olympic medals in Beijing 2008 and Vancouver 2010 Olympic Games. A consultation of the coaches of these National Teams revealed that although a large proportion of these athletes present various cardio-respiratory symptoms, they do not have a rapid access to a systematic medical evaluation and follow-up. Furthermore, little is done in regard to prevention and optimization of treatment of pulmonary and cardiac conditions in the elite athlete's population of the Quebec area.
Cardiorespiratory problems are therefore commonly found in high-level athletes. However, these pathologies are not well characterized in athletes and the associated symptoms often not well perceived. These problems can be serious and it is important to detect them before they appear1 while setting up a systematic medical follow-up. Health professionals should monitor health of the young athletes and help to reduce the risks associated with high level exercise. The following project is an evaluation and follow-up program of high-level athletes, aiming at gathering key-information on long-term effects of high-level training on cardio-respiratory and metabolic parameters. Our aims will be
Condition |
Asthma Cardiovascular Diseases Metabolic Diseases |
MedlinePlus related topics: | Asthma Metabolic Disorders |
Study Type: | Observational |
Study Design: | Case Control, Prospective |
Official Title: | Center of Excellence in CardioRespiratory Health of High-Level Athletes: Evaluation of Long-Term Effects of Training. |
Serum - plasma - sputum
Estimated Enrollment: | 100 |
Study Start Date: | June 2007 |
Estimated Study Completion Date: | December 2010 |
Estimated Primary Completion Date: | December 2010 (Final data collection date for primary outcome measure) |
Groups/Cohorts |
1
Triathletes
|
2
Cold air athletes
|
3
Swimmers
|
4
Other sports elite athletes
|
5
Control subjects
|
Ages Eligible for Study: | 14 Years to 45 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Athletes training in the province of Quebec. Controls from Quebec schools and universities.
Inclusion Criteria:
Exclusion Criteria:
Contact: Julie TURMEL, PhD | 418-656-8711 ext 2814 | julie.turmel@crhl.ulaval.ca |
Contact: Paul Poirier, MD | 418-656-8711 | paul.poirier@crhl.ulaval.ca |
Canada | |||||
Centre de recherche en pneumologie et cardiologie de l'hôpital Laval | Recruiting | ||||
Quebec, Canada, G1V4G5 | |||||
Contact: Julie TURMEL, MSc 418-656-8711 ext 2814 julie.turmel@crhl.ulaval.ca | |||||
Contact: Paul POIRIER, MD 418-656-8711 jpaul.poirier@crhl.ulaval.ca | |||||
Principal Investigator: Louis-Philippe BOULET, MD | |||||
Principal Investigator: Paul POIRIER, MD |
Laval University |
Principal Investigator: | Paul POIRIER, MD | Hôpital LAval |
Principal Investigator: | Paul POIRIER, MD | Hôpital Laval |
Responsible Party: | Hôpital Laval ( Dr Louis-Philippe BOULET ) |
Study ID Numbers: | CER 20141 |
First Received: | May 26, 2008 |
Last Updated: | May 28, 2008 |
ClinicalTrials.gov Identifier: | NCT00686491 |
Health Authority: | Canada: Canadian Institutes of Health Research |
|
|
|
|
![]() |